How many institutions held LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share in Q4 2021?

116 institutional investors reported LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share for Q4 2021. Use the holders table for investor-level position and value details.

STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB)

Q: What does CUSIP 34385P108 represent in this 13F holders report?

CUSIP 34385P108 is the security identifier for LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 34385P108

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 384,731,503
Total 13F shares: 56,282,734
Share change: -3,017,176
Total reported value: $220,394,393
Put/Call ratio: 51%
Price per share: $3.92
Number of holders: 116
Value change: -$14,652,768
Number of buys: 49
Number of sells: 60

Quarterly Holders Quick Answers

What is CUSIP 34385P108?
CUSIP 34385P108 identifies LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 34385P108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Indaba Capital Management, L.P.	13F	Company	1.9%	7,446,229	$49,071,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	1.7%	6,350,729	$41,851,000	—	30 Sep 2021	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	1.4%	5,263,043	$34,683,000	—	30 Sep 2021	13F
ORBIMED ADVISORS LLC	13F	Company	1.2%	4,599,571	$30,311,000	—	30 Sep 2021	13F
Neuberger Berman Group LLC	13F	Company	1.1%	4,280,190	$27,714,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	0.93%	3,586,879	$23,638,000	—	30 Sep 2021	13F
NEEDHAM INVESTMENT MANAGEMENT LLC	13F	Company	0.86%	3,290,000	$21,682,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.74%	2,852,514	$18,798,000	—	30 Sep 2021	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.6%	2,302,278	$15,172,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.5%	1,931,835	$13,406,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	0.38%	1,452,282	$9,571,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.35%	1,349,759	$8,894,000	—	30 Sep 2021	13F
Tikvah Management LLC	13F	Company	0.32%	1,250,000	$8,237,500	—	30 Sep 2021	13F
PFM Health Sciences, LP	13F	Company	0.25%	980,505	$6,462,000	—	30 Sep 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.25%	951,857	$6,272,000	—	30 Sep 2021	13F
PARADIGM CAPITAL MANAGEMENT INC/NY	13F	Company	0.24%	916,000	$6,036,000	—	30 Sep 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.21%	789,207	$5,201,000	—	30 Sep 2021	13F
UBS Group AG	13F	Company	0.2%	788,162	$5,194,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.2%	756,748	$4,988,000	—	30 Sep 2021	13F
PERKINS CAPITAL MANAGEMENT INC	13F	Company	0.14%	520,825	$3,432,000	—	30 Sep 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.1%	400,000	$2,636,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.1%	377,553	$2,489,000	—	30 Sep 2021	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.08%	318,991	$2,102,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.08%	289,501	$1,909,000	—	30 Sep 2021	13F
SILVERBACK ASSET MANAGEMENT LLC	13F	Company	0.07%	285,744	$1,883,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.07%	282,044	$1,858,000	—	30 Sep 2021	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.07%	267,017	$1,760,000	—	30 Sep 2021	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.06%	244,116	$1,609,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.05%	191,465	$1,262,000	—	30 Sep 2021	13F
Alexandria Capital, LLC	13F	Company	0.05%	188,700	$1,244,000	—	30 Sep 2021	13F
SkyOak Wealth, LLC	13F	Company	0.05%	181,885	$1,199,000	—	30 Sep 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.04%	171,457	$1,130,000	—	30 Sep 2021	13F
Employees Retirement System of Texas	13F	Company	0.04%	165,000	$1,087,000	—	30 Sep 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.04%	161,188	$1,062,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.04%	158,354	$1,043,000	—	30 Sep 2021	13F
Swiss National Bank	13F	Company	0.04%	156,100	$1,029,000	—	30 Sep 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.04%	151,665	$999,000	—	30 Sep 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.04%	145,618	$960,000	—	30 Sep 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	134,856	$889,000	—	30 Sep 2021	13F
PDT Partners, LLC	13F	Company	0.03%	127,900	$843,000	—	30 Sep 2021	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.03%	117,906	$777,000	—	30 Sep 2021	13F
Intellectus Partners, LLC	13F	Company	0.03%	116,768	$770,000	—	30 Sep 2021	13F
CITIGROUP INC	13F	Company	0.03%	115,408	$761,000	—	30 Sep 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	105,527	$695,000	—	30 Sep 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	99,791	$658,000	—	30 Sep 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.02%	92,399	$608,909	—	30 Sep 2021	13F
Invesco Ltd.	13F	Company	0.02%	76,468	$504,000	—	30 Sep 2021	13F
Caption Management, LLC	13F	Company	0.02%	73,525	$485,000	—	30 Sep 2021	13F
Connacht Asset Management LP	13F	Company	0.02%	65,065	$429,000	—	30 Sep 2021	13F
CREDIT SUISSE AG/	13F	Company	0.02%	63,507	$418,000	—	30 Sep 2021	13F

Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q4 2021

As of 31 Dec 2021, STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,282,734 shares. The largest 10 holders included Indaba Capital Management, L.P., BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, Neuberger Berman Group LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, NEEDHAM INVESTMENT MANAGEMENT LLC, BOOTHBAY FUND MANAGEMENT, LLC, Nuveen Asset Management, LLC, and STATE STREET CORP. This page lists 116 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

116

Q4 2021 holders

116

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.